# Krebs Biochemicals & Industries Ltd-$ (KREBSBIO)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹67.15
Day Change: +3.29%
52W High: ₹113.9
52W Low: ₹38.52
Market Cap: ₹125 Cr

## Valuation
P/E: 0
P/B: -0.78
EPS: ₹-10.6
Book Value: ₹0
Dividend Yield: 0%

## Returns
1Y Return: -2.67%

## Profitability
ROE: 0%
ROCE: 0%
Debt/Equity: 0
Revenue Growth: -36.6%
Profit Growth: 0%
EBITDA Margin: -42.96%
Operating Margin: -18.33%

## About
Krebs Biochemicals & Industries Ltd-$ is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Krebs Biochemicals & Industries Ltd-$ makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
- Announcement: Clarification On Price Movement
- BSE Filing: Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-06-08T20:00:07.519Z
Price History Updated: 2026-06-10T02:01:20.912Z
Latest Price History Date: 2026-06-08
Technicals Updated: 2026-06-10T02:01:20.912Z
Quant Updated: 2026-06-10T02:01:20.912Z
Sentiment Updated: 2026-06-10T02:01:20.912Z
Financials Status: current
Financials Updated: 2026-05-18T23:05:41.654Z
Financials Last Attempt: 2026-05-18T23:05:41.654Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹43.31 Cr
Operating Profit: ₹-21.3 Cr (OPM -49.18%)
Net Profit: ₹-26.94 Cr
Tax: ₹0.02 Cr

## Annual P&L History
FY25: Rev ₹43.31Cr | PAT ₹-26.94Cr | OPM -49.18%
FY24: Rev ₹50.42Cr | PAT ₹-19.73Cr | OPM -30.15%
FY23: Rev ₹52.13Cr | PAT ₹-24.69Cr | OPM -42.09%

## Balance Sheet (FY25)
Total Assets: ₹169.04 Cr
Total Liabilities: ₹315.27 Cr
Borrowings: ₹257.21 Cr
Cash: ₹0.02 Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Rakesh R. Kalbate, Company Secretary & Compliance Officer
- Manish Kumar Jain, MD, CEO & Director
- Ritesh  Jain, Chief Financial Officer

---
Source: rupiya.io/stocks/krebsbio
Disclaimer: For research and education only. Not investment advice.